&Partners’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$346K Buy
25,462
+1,001
+4% +$15K ﹤0.01% 1898
2025
Q4
$376K Buy
+24,461
New +$392K ﹤0.01% 1778
2024
Q3
Sell
-10,353
Closed -$182K 1394
2024
Q2
$182K Buy
+10,353
New +$176K 0.01% 859

Other funds holding ECAT

&Partners's ECAT Position: Q1 2026 in Review

&Partners increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 4.1% in Q1 2026, buying an estimated $15K and bringing the position to 25,462 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1898.

&Partners first reported a position in ECAT in Q2 2024 and has held it in 3 quarters since. The position peaked at $376K in Q4 2025. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.

  • &Partners held 25,462 shares of BlackRock ESG Capital Allocation Term Trust worth $346K as of Q1 2026.
  • &Partners bought 1,001 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $15K.
  • BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1898 holding.
  • &Partners first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2024 and has held it in 3 quarters since.
  • &Partners's BlackRock ESG Capital Allocation Term Trust position peaked at $376K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.